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LC–MS/MSAbstract To investigate and compare the detection of isomers on the basis of analyte adduct for-
mation with the components of the mobile phase appropriate infusion experiments were performed
with tandem mass spectrometry (Q1MS, EPI and MRMmode) and analyses with liquid chro-
matography–tandem mass spectrometry (ESI). In experiments performed following adducts were
focused: deprotonated analyte adduct with sodium acetate, deprotonated analyte dimer adduct with
sodium and deprotonated analyte adduct with two molecules of sodium acetate. a-hydroxybutyrate,
b-hydroxybutyrate and c-hydroxybutyrate were used as model drugs since their effective separation
and detection are a real analytical challenge when c-hydroxybutyrate is the analyte of interest. The
achieved results revealed that the drugs investigated produce similar adduct ions in the
negative electrospray mode. However, b-hydroxybutyrate is not a potential interfering
substance for c-hydroxybutyrate analysis other than a-hydroxybutyrate. The interference
of a-hydroxybutyrate can be minimised when analyte adduct ion fragmentation is used, since
appropriate fragmentations do not produce ion fragments (m/z = 85) with efficiency required at
different values of collision energy. Finally it was demonstrated that the strategy presented can
be a real advantage when interfering substances with similar retention times do not produce adduct
ions or produce adduct ions but with a different fragmentation pattern.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Liquid chromatography–tandem mass spectrometry (LC–MS/MS) is
one of the most widely used analytical techniques applied for different
purposes (Bhaskara et al., 2011; Dziadosz et al., 2014a; Jain et al.,
2015; Venugopal et al., in press; Wang et al., in press). However, an
important limitation of LC–MS/MS is the detection of small molecules
since they can produce very small ion fragments or do not produce any
stable ion fragments at all (Dziadosz et al., 2014b). The traditional way
to analyse this problematic substances with LC–MS/MS is based onem mass
2 M. Dziadoszthe detection of a pseudo mass transition which in fact is a simple mon-
itoring of the protonated or deprotonated drug (Gao et al., 2011; Jain
et al., 2007; Kim et al., 2011; Matsuura et al., 2008; Shibata et al.,
2012). Therefore, the advantage of liquid chromatography–tandem
mass spectrometry based on real mass transitions (defined contrary
to pseudo mass transitions) as a consequence of analyte structural
change cannot be applied in drug identification/quantification.
The latest research demonstrated that the problems mentioned can
be solved by the application of the analyte adduct formation process
with the components of the mobile phase such as sodium acetate
and acetic acid if appropriate buffers are used. Analyte adduct ions
can be applied to generate bigger ion fragments, when the analyte pro-
duces very small ones or to generate real mass transitions in cases when
the analyte does not produce any stable ion fragments at all (Dziadosz
et al., 2014c, 2013). A recent paper demonstrated also that this analyt-
ical strategy can be applied to generate MS3 mass transitions of small
molecules (Dziadosz, 2015a). As a consequence these problematic sub-
stances can be analysed with LC–MS3 with higher sensitivity.
In previous papers it was stated that the analyte adduct formation
process is an interesting alternative especially for small drugs whose
fragmentation is problematic (Dziadosz et al., 2014b, 2013). The appli-
cation of analyte adduct formation opened a way to generate MS2 and
MS3 mass transitions for these small molecules (Dziadosz, 2015a;
Dziadosz et al., 2014c). An effective validation/quantification could
also be performed with LC–MS/MS on the basis of forensic guidelines.
The application of this strategy for drugs whose fragmentation is not
problematic was thought to be limited (in some methods if sensitivity
problems occur) or even without analytical sense. However, the study
of analyte adduct formation induced a consideration about the similar-
ities/differences in isomer adduct formation and about possible appli-
cations if differences occur. Therefore, the aim of this paper was to
investigate the analyte adduct formation/fragmentation of similar sub-
stances which can be characterised by the same molecular mass but
slight differences in the structure. An analyte group that fulfils these
requirements can be represented by a- (AHB), b- (BHB)
and c-hydroxybutyrate (GHB) (Fig. 1) with molecular masses (M)
= 104 Da. These substances were used as model compounds for the
appropriate investigation. AHB and BHB are substances which can
interfere with GHB when a GHB analysis is performed for forensic/-
clinical purposes. GHB itself is an endogenous molecule; however, it
gained public attention as a drug of abuse. Thus, these model com-
pounds represent a real analytical challenge in the field mentioned.
A validated method for GHB analysis in human serum on the basis
of analyte adduct formation was already presented (Dziadosz, 2015a;
Dziadosz et al., 2013).
Since the application of different analyte adduct ions can also
improve method sensitivity in some applications, they have been used
for a long time in LC–MS/MS analysis especially in cases, when theFigure 1 The chemical structure of AHB, BHB and GHB.
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tory. An example is the analysis of sirolimus or asiatic acid based on
ammonium adduct ions (Kushnir et al., 2005; Nair et al., 2012;
Vogeser et al., 2002). However, the advantage of adduct detection in
minimising the problem of interfering substances was not investi-
gated/described. Therefore, the study presented was focused on the
possibility of using analyte adduct formation/fragmentation to
improve mass transition specificity of problematic molecules for MSn
detection. Furthermore, the observation examined and described on
the basis of different AHB/BHB/GHB signals in this paper (mass tran-
sition of: deprotonated analyte, deprotonated analyte adduct with
sodium acetate, deprotonated analyte dimer adduct with sodium and
deprotonated analyte adduct with two molecules of sodium acetate)
could signal the possibility to use the analyte adduct formation/frag-
mentation strategy presented earlier not only for small drugs which
are problematic in their detection when LC–MS/MS is applied but also
for all other drugs with appropriate molecular structure for adduct for-
mation and different problems with interfering matrix components.
2. Materials and methods
An Applied Biosystems API 4000 QTrap tandem mass spec-
trometer operated in the negative electrospray ionisation mode
and a Shimadzu UFLC Prominence System equipped with two
solvent delivery units (LC-20AD), Communication Bus Mod-
ule (CBM-20A), Autosampler (SIL-20AC HT), degasser
(DGU-20 A3) and column oven (CTO-10 AS VP) were used
in the study. Data acquisition was performed by the Analyst
1.5 software. Chemicals/solvents used were of analytical/LC–
MS grade and purchased from the following: Merck (Darm-
stadt, Germany), J.T. Baker (Deventer, Netherlands) and
Sigma–Aldrich (Taufkirchen, Germany). ESI-MS/MS was
performed in the negative scan mode (Q1 MS), negative
enhanced product ion mode (EPI) and negative multiple
reaction monitoring mode (MRM) with the following
source/gas parameters: curtain gas (N2) – 10 psi, collision gas
(N2) – high, temperature – 0, ion source gas 1 (N2) – 22 psi,
ion source gas 2 (N2) – 0 psi, ion spray voltage – 4500 V.
Additionally, the Q1 MS mode used for the adduct identifi-
cation experiments was performed with following declustering
(DP) and entrance potential values (EP): 60 V and 10 V
respectively and the EPI mode used for the fragmentation
experiments was performed with following DP, collision
energy (CE) and collision energy spread (CES) values:
60 V, 20 V and 10 V. The MRM mode was used to inves-
tigate the influence of CE on signal intensity at a given mass
transition at DP = 60.
A 1 mg/mL stock solution of each substance investigated
(AHB/BHB/GHB) was prepared in methanol and used for
the preparation of infusion solutions. Appropriate dilutions
were performed in methanol with 1 mmol L1/10 mmol L1
CH3COONa/CH3COOH. A continuous infusion at a flow rate
of 10 lL/min of each diluted substance (1 and 10 lg/mL) made
the adduct identification/fragmentation experiments possible.
By the application of this strategy it was expected that the infu-
sion experiments performed on the basis of these solutions will
reveal that signal intensities of some m/z values increase in the
higher concentrated drug solution. One of these m/z values
would be related to the deprotonated analyte and other values
with a comparable signal increase would be related to appro-
priate analyte adduct ions. The calculated differences of m/z
values related to the analyte adduct ions and m/z values related
to the deprotonated analyte would characterise the masste adduct formation with the components of the mobile phase and tandem mass
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would made the adduct identification possible.
The application of Q1 MS experiments was aimed to be
used to identify adduct ions formed under conditions applied
and to compare the analyte adduct formation of substances
with small differences in the structure and the same molecular
mass (AHB, BHB, GHB). EPI experiments were planned to
be used to identify possible mass transitions of adducts charac-
terised by the Q1 experiments. Finally these mass transitions
were planned to be investigated by MRM experiments to
answer the question if the analyte adduct formation process
with the components of the mobile phase can be applied suc-
cessfully to ‘‘separate” the GHB detection performed in the
forensic/clinical toxicology on the basis of MS/MS systems
from signals generated by other substances with the same
molecular mass and similar structure. These problematic sub-
stances are relevant, since only slight differences in the struc-
ture in comparison with the analyte lead to similar retention
times, when liquid chromatography–tandem mass spectrome-
try is used in the analysis. Therefore, they are a potential inter-
ference and can cause important separation problems
especially when the analyses are performed by the application
of reversed-phase chromatography.
3. Results and discussion
The Q1 MS experiments performed on the basis of 1 and
10 lg/mL infusion solutions made the identification of follow-Figure 2 Q1 mass spectrum registered in the m/z rang
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spectrometry. Arabian Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabing AHB (Fig. 2)/BHB/GHB signals possible: deprotonated
analyte ([M – H], m/z= 103 Da), deprotonated analyte
adduct with sodium acetate ([M – H+ CH3COONa]
,
m/z= 185 Da), deprotonated analyte adduct with analyte
([2M – H], m/z= 207 Da), deprotonated analyte dimer
adduct with sodium ([2M – 2H+ Na], m/z= 229 Da) and
deprotonated analyte adducts with n molecules (n= 1–10) of
sodium acetate ([M – H+ nCH3COONa]
, m/z= 103
+ n82 Da). An interesting observation made is the fact, that
analyte adducts even with 10 molecules of sodium acetate
could be identified during experiments performed (m/
z= 923). However, in this work only analyte adducts with
no more than two molecules of sodium acetate were investi-
gated further (m/z= 267).
The Q1 MS experiments revealed that AHB, BHB and
GHB form the same analyte adducts with the components of
the mobile phase with comparable signal intensities under con-
ditions applied. An example of the Q1 mass spectrum regis-
tered for AHB is presented in Fig. 2.
The deprotonated analyte/analyte adduct fragmentation
was investigated on the basis of EPI experiments which
revealed that the fragmentation of analyte adduct ions is com-
parable to the fragmentation of appropriate deprotonated ana-
lytes (Fig. 3). However, other fragments with bigger masses
could also be identified.
GHB produces a mass fragment at m/z= 85 among other
signals with lower intensity. Based on the small molecule of
GHB its fragmentation can be defined as poor. Therefore,e from 40 to 500 for the 10 lg/mL AHB solution.
te adduct formation with the components of the mobile phase and tandem mass
jc.2016.06.005
4 M. Dziadoszthe mass transition 103/85 is applied widely together with the
detection of very small ion fragments (m/z< 85) for LC–
MS/MS analysis when ESI is used in the traditional way
without adduct formation (Dresen et al., 2007; Elian and
Hackett, 2011; Lott et al., 2012; Sørensen and Hasselstrøm,
2012; Stout et al., 2010). Since the mass transition 103/85
enables to work with the best sensitivity it is used as target
in MS/MS detection. However, this transition can be explained
presumably by the loss of water and it is well known that such
mass changes resulting from commonly lost small fragments
tend to be non-specific (Kushnir et al., 2005). Other mass tran-
sitions based on the detection of even smaller problematic ion
fragments are applied as qualifier. Although, in this way two
mass transitions are used as required in forensic applications,
GHB has to be seen as problematic molecule for traditional
LC–MS/MS analyses (Peters et al., 2009). AHB and BHB
are molecules which can interfere with GHB since their molec-
ular weights are the same. Therefore an appropriate separation
with different stationary phases is necessary when one of these
substances is analysed with LC–MS/MS (Sørensen et al.,
2013). In particular, the method selectivity between AHB
and GHB has to be evaluated since BHB does not produce
the 103/85 mass transition in ESI.
Since it was stated above that the fragmentation of analyte
adduct ions is comparable to the fragmentation of appropriate
deprotonated analytes (EPI experiments) it was interesting to
evaluate whether the m/z= 85 ion fragment is generatedFigure 3 EPI mass spectra of AHB
Please cite this article in press as: Dziadosz, M. Isomer detection on the basis of analy
spectrometry. Arabian Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabefficient enough by adduct fragmentation. Because the MS/
MS signal intensity is affected strongly by CE, signal intensi-
ties of appropriate AHB, BHB and GHB adduct ions identi-
fied on the basis of Q1 MS experiments were monitored at
different values of CE applied in MRM experiments
(Fig. 4). The results revealed that GHB adduct ions form
stable ion fragments at m/z= 85. Therefore, signals with
appropriate intensities can be expected when the mass transi-
tions investigated are used for GHB detection in LC–MS/
MS analysis. On the other hand, like expected BHB adduct
ions do not form stable ion fragments (m/z= 85) since the
deprotonated BHB does not form this ion fragment neither
(Fig. 3). This fact can be pointed out by CE functions obtained
(Fig. 4). Thus, it can be stated that BHB is not a potential
interfering molecule when ESI is used for GHB analysis with
liquid chromatography–tandem mass spectrometry on the
basis of m/z= 85 ion fragment detection.
AHB is a potential interfering drug for GHB analysis since
the mass transition 103/85 can also be generated (Fig. 3). Since
the AHB CE function of this mass transition is comparable to
the CE function of GHB, the AHB interference cannot be
eliminated by the application of a different CE value. When
CE functions of appropriate AHB and GHB adducts are com-
pared it can be observed that all GHB adducts investigated
form stable ion fragments at m/z= 85. This tendency cannot
be confirmed by AHB adduct ion fragmentation since only
for the 185/85 mass transition a CE function can be supposed, BHB and GHB (all 10 lg/mL).
te adduct formation with the components of the mobile phase and tandem mass
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Figure 4 MRM experiments with CE ramping (signal intensity as a function of collision energy) – all 10 lg/mL.
Isomer detection on the basis of analyte adduct formation 5(Fig. 4). Other signal intensities registered for AHB adducts
(mass transitions: 229/85 and 267/85) on the basis of CE ramp-
ing can be defined as background noise comparable with BHB
adduct signals (Fig. 4). This finding is very interesting since it
suggests that by the application of GHB adduct ion fragmen-
tation an important problem concerning the AHB interference
(ESI) can be solved not only by the application of an appro-
priate separation column but also by the way of analyte
detection.
The advantage of analyte adduct formation/fragmentation
in solving the problem of AHB interference in GHB analysis
with LC–MS/MS is presented in Fig. 5. For the analysis pre-
sented two solutions, one with 10 lg/mL AHB and another
with 10 lg/mL GHB, were prepared in methanol with
1 mmol L1/10 mmol L1 CH3COONa/CH3COOH. Chro-
matographic separation was performed with a Luna 5 lm
C18 (2) 100 A, 150 mm  2 mm column (Phenomenex,
Aschaffenburg, Germany) and the elution with a mobile phasePlease cite this article in press as: Dziadosz, M. Isomer detection on the basis of analy
spectrometry. Arabian Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabconsisting of 10% A (H2O/methanol = 95/5, v/v) and 90% B
(H2O/methanol = 3/97, v/v), both with 10 mM ammonium
acetate and 0.1% acetic acid. The injection volume was
10 lL and the flow program used was as follows: starting with
0.05 mL/min, ramping to 0.4 mL/min from 0.0 to 1.5 min,
holding 0.4 mL/min from 1.5 to 2.2 min, reducing to
0.05 mL/min from 2.2 to 2.5 min, and holding 0.05 mL/min
from 2.5 to 3.0 min. The MS/MS was operated in the MRM
mode with following conditions (Q1 mass/Q2 mass = 267/85):
time = 100 ms, DP = 60, EP = 10, CE = 25, cell exit
potential (CXP) = 5, curtain gas (N2) – 25 psi, collision
gas (N2) – medium, ion source gas 1 and 2 (N2) – 80 psi, tem-
perature – 400 C, ion spray voltage – 4500 V. The condi-
tions chosen did not guarantee a successful AHB/GHB
separation; therefore, an AHB interference occurs when the
traditional GHB MS/MS detection is applied (data not
shown). However, the results achieved demonstrated that the
AHB interference can be minimised on the basis of the analytete adduct formation with the components of the mobile phase and tandem mass
jc.2016.06.005
Figure 5 Chromatogram of a 10 lg/mL AHB and GHB solution in methanol with 1 mmol L1/10 mmol L1 CH3COONa/CH3COOH
registered at m/z= 267/85.
6 M. Dziadoszadduct formation/fragmentation process since only back-
ground noise could be observed for AHB at the retention time
expected (Fig. 5). Thus, this strategy can be a real advantage in
GHB analysis in biological material after appropriate method
optimisation. Since the analyte adduct formation is a promis-
ing alternative for drug analysis, the study presented is an
important continuation of previous papers (Dziadosz, 2016a,
2016b, 2015a, 2015b; Dziadosz et al., 2014b, 2014c, 2013).
4. Conclusion
AHB, BHB and GHB produce similar adduct ions in the negative elec-
trospray mode. BHB is not a potential interfering substance for GHB
analysis since the ion fragment at m/z= 85 is not produced neither by
BHB ion nor by BHB adduct ion fragmentation. AHB is a potential
interfering drug for GHB analysis (ESI) when traditional mass tran-
sitions are used. The interference of AHB can be minimised when ana-
lyte adduct ion fragmentation is used since appropriate fragmentations
to m/z= 85 do not produce ion fragments with efficiency required at
different values of collision energy.
The analyte adduct formation process can be a real benefit when
interfering substances with similar retention times do not produce
adduct ions or produce adduct ions but with a different fragmentation
pattern like presented in this paper. Therefore, this process can be con-
sidered for application not only for small drugs which are problematic
in their detection when liquid chromatography–tandem mass spec-
trometry is applied but also for all other drugs with appropriate molec-
ular structure for adduct formation and different problems with
interfering matrix components.
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